1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (6438)
  2. Meeting Abstract (5172)
  3. Review (332)
  4. Book Section (310)
  5. Editorial (92)
  6. Research Letter (73)
  7. Guidelines (52)
  8. Correspondence (47)
  9. Conference Paper (38)
  10. Miscellaneous (37)
  11. Book Whole (24)
Groups
  1. Department of Pathology and Laboratory Medicine (12615)
  2. GSK Faculty (4773)
  3. Department of Medicine (4722)
  4. Surgery (3639)
  5. Solid Tumor Oncology Division (3422)
  6. Human Oncology and Pathogenesis Program (3037)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Victor Reuter (1228)
  3. Cristina Antonescu (895)
  4. Michael Berger (765)
  5. William Travis (743)
  6. Jinru Shia (719)

More People

Years
  1. 2025 (307)
  2. 2024 (719)
  3. 2023 (766)
  4. 2022 (841)
  5. 2021 (677)
  6. 2020 (787)

More Years

Publications
  1. Laboratory Investigation (1448)
  2. Modern Pathology (1440)
  3. Journal of Clinical Oncology (863)
  4. American Journal of Surgical Pathology (429)
  5. Cancer Research (426)
  6. Blood (349)

More Publications

Publishers
  1. Nature Publishing Group (1939)
  2. Nature Research (1457)
  3. Elsevier Inc. (1139)
  4. American Society of Clinical Oncology (955)
  5. American Association for Cancer Research (923)
  6. Lippincott Williams & Wilkins (896)

More Publishers

Results (12615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identification of pretreatment genomic biomarkers and mechanisms of acquired resistance to first-line osimertinib in advanced EGFR-mutant lung cancers
    Meeting Abstract

    Choudhury, N. J.; Marra, A.; Yang, S. R.; Falcon, C. J.; Heller, G.; Kris, M. G.; Reis-Filho, J. S.; Riely, G. J.; Yu, H. A.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Single agent PD-1 blockade as curative-intent treatment in mismatch repair deficient locally advanced rectal cancer
    Meeting Abstract

    Cercek, A.; Lumish, M. A.; Sinopoli, J. C.; Weiss, J. A.; Shia, J.; Stadler, Z. K.; Yaeger, R.; Smith, J. J.; Saltz, L. B.; El Dika, I. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)
    Meeting Abstract

    Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase I trial of adjuvant autogene cevumeran, an individualized mRNA neoantigen vaccine, for pancreatic ductal adenocarcinoma
    Meeting Abstract

    Balachandran, V. P.; Rojas, L. A.; Sethna, Z.; Soares, K.; Derhovanessian, E.; Mueller, F.; Yadav, M.; Basturk, O.; Gonen, M.; Wei, A. C. C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Germline risk assessment and genetic counseling in ovarian cancer patients of diverse self-reported race/ethnicity and ancestry
    Meeting Abstract

    Sia, T.; Maio, A.; Gordhandas, S.; Kahn, R.; Kemel, Y.; Salo-Mullen, E.; Sheehan, M.; Tejada, P. R.; Roche, K. L.; Chi, D.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save
  • Towards microscopic level dosimetry for colorectal hepatic metastases treated with trans-arterial (90)Y radioembolization using micro-CT and autoradiography of (90)Y PET/CT-guided biopsy specimens
    Meeting Abstract

    Kirov, A.; Naydenov, N.; Nie, X.; Talarico, O.; Teplov, A.; Zirakchian Zadeh, M.; Ruan, S.; Iraca, M.; Kunin, H.; Miller, B. W.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2022)

    Fulltext@MSK | Save
  • Vepafestinib is effective in preclinical models of sarcomas with RET fusion including a brain metastasis model
    Meeting Abstract

    Odintsov, I.; Liu, A.; Khodos, I.; Chang, Q.; Giuliano, C.; Mattar, M.; Vojnic, M.; Bonifacio, A.; De Stanchina, E.; Lovati, E.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Growth factor signaling and kinase inhibitors regulate oncogenesis in desmoid fibromatosis by modulating activity of the beta-catenin transcription target ABL1
    Meeting Abstract

    Hu, J.; Villano, A.; O'Connor, R.; Rozenberg, Y.; Venkatesh, A.; Gounder, M.; Socci, N.; Singer, S.; Hameed, M.; Crago, A. M.
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Inducible transgenic cerebral organoids model oncogene dependence in pediatric tumorigenesis
    Meeting Abstract

    Graham, M. S.; Codega, P.; Campos, C.; Rosenblum, M. K.; Antonescu, C. R.; Nandakumar, S.; Benhamida, J. K.; Bale, T. A.; von Deimling, A.; Socci, N. D.; more...
    Annals of Neurology (2022)

    Fulltext@MSK | Save
  • Uterine leiomyosarcoma with a novel RAB2A-PLAG1 gene fusion
    Meeting Abstract

    Hosseini, H.; Vele, O.; Unger, P.; O'Leary, X.; DiNapoli, S. E.; Mullaney, K.; Zaidinski, M.; Sukhadia, P.; Benhamida, J. K.; Soslow, R. A.; more...
    American Journal of Clinical Pathology (2022)

    Fulltext@MSK | Save